BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15014029)

  • 1. Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.
    Kambara T; Sharp GB; Nagasaka T; Takeda M; Sasamoto H; Nakagawa H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
    Clin Cancer Res; 2004 Mar; 10(5):1758-63. PubMed ID: 15014029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of genetic deletions on chromosome 3 in colorectal cancer: loss of 3p25-pter is associated with distant metastasis and poor survival.
    Tsai MH; Fang WH; Lin SH; Tzeng ST; Huang CS; Yen SJ; Chou SJ; Yang YC
    Ann Surg Oncol; 2011 Sep; 18(9):2662-70. PubMed ID: 21347784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
    Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
    Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
    Halling KC; French AJ; McDonnell SK; Burgart LJ; Schaid DJ; Peterson BJ; Moon-Tasson L; Mahoney MR; Sargent DJ; O'Connell MJ; Witzig TE; Farr GH; Goldberg RM; Thibodeau SN
    J Natl Cancer Inst; 1999 Aug; 91(15):1295-303. PubMed ID: 10433618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.
    Lindforss U; Fredholm H; Papadogiannakis N; Gad A; Zetterquist H; Olivecrona H
    Cancer; 2000 Jun; 88(12):2661-7. PubMed ID: 10870047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma.
    Iniesta P; Massa MJ; González-Quevedo R; de Juan C; Morán A; Sánchez-Pernaute A; Cerdán J; Torres A; Balibrea JL; Benito M
    Cancer; 2000 Sep; 89(6):1220-7. PubMed ID: 11002216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival.
    Choi SW; Lee KJ; Bae YA; Min KO; Kwon MS; Kim KM; Rhyu MG
    Clin Cancer Res; 2002 Jul; 8(7):2311-22. PubMed ID: 12114436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.
    Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P
    Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ; Qin LX; Ren N; Hei ZY; Ye QH; Jia WD; Sun BS; Lin GL; Liu DY; Liu YK; Tang ZY
    Clin Cancer Res; 2007 Dec; 13(24):7363-9. PubMed ID: 18094418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
    Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
    J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
    Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
    J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity: an independent prognostic factor of colorectal cancer.
    Chang SC; Lin JK; Lin TC; Liang WY
    World J Gastroenterol; 2005 Feb; 11(6):778-84. PubMed ID: 15682467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite alterations in serum DNA of patients with colorectal cancer.
    Kölble K; Ullrich OM; Pidde H; Barthel B; Diermann J; Rudolph B; Dietel M; Schlag PM; Scherneck S
    Lab Invest; 1999 Sep; 79(9):1145-50. PubMed ID: 10496533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of sporadic colon cancer by patterns of genomic instability.
    Goel A; Arnold CN; Niedzwiecki D; Chang DK; Ricciardiello L; Carethers JM; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
    Cancer Res; 2003 Apr; 63(7):1608-14. PubMed ID: 12670912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic imbalance and microsatellite instability in resected Duke's D colorectal cancer.
    Kochhar R; Halling KC; McDonnell S; Schaid DJ; French AJ; O'Connell MJ; Nagorney DM; Thibodeau SN
    Diagn Mol Pathol; 1997 Apr; 6(2):78-84. PubMed ID: 9098645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
    Arribas R; Ribas M; Risques RA; Masramon L; Tórtola S; Marcuello E; Aiza G; Miró R; Capellà G; Peinado MA
    Clin Cancer Res; 1999 Nov; 5(11):3454-9. PubMed ID: 10589758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.